Document is current
Any future updates will be listed below
-
Authors
Mendel, Mateusz https://orcid.org/0009-0008-2592-1881
Schwarz, Dominic https://orcid.org/0000-0002-0322-5059
Sun, Tao
Tan, Sophia
Franceschetti, Asia
Majcher, Daria
Lang, Simone
Venetz, Dario
Ratni, Hasane https://orcid.org/0000-0002-8151-8295
Jagasia, Ravi
Ebeling, Martin https://orcid.org/0000-0002-0361-4636
Roudnicky, Filip https://orcid.org/0000-0001-7156-2383
Schukur, Lina https://orcid.org/0009-0009-8150-9928
-
Funding
Funding for this research was provided by:
Roche
- License Information
-
More Information
Article History
Received: 3 July 2025
Accepted: 18 May 2026
First Online: 30 May 2026
Competing interests
: This study is supported by F. Hoffmann-La Roche Ltd and Genentech Inc. M.M., D.S., T.S., S.T., A.F., D.M., S.L., D.V., H.R., R.J., M.E., F.R., and L.S. were employees, master or PhD students of F. Hoffmann-La Roche at the time of performing the research. H.R. is currently employed at Skyhawk Therapeutics (Switzerland). D.S. and S.L. were supported by the F. Hoffmann-La Roche doctoral fellowship.
